Navigation Links
Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment
Date:6/9/2009

Customizable Survival Kit Offers One Stop for Market-Specific Managed Care Enrollment Data and Insights into Local Healthcare Market Drivers and Health Plan Trends

NASHVILLE, Tenn., June 9 /PRNewswire/ --HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that commercial pharmacy enrollment is experiencing greater shifts in membership at the state level than commercial medical benefit enrollment. According to new data from HealthLeaders-InterStudy, Florida is one market in which commercial medical and pharmacy benefit enrollment is moving in different directions. Between January 2008 and January 2009, commercial medical enrollment in Florida grew by nearly three percent, while commercial pharmacy enrollment decreased by 10 percent.

Enrollment details, along with insights into local healthcare market drivers and health plan trends can be found in a customizable Survival Kit from HealthLeaders-InterStudy. The Kit, which can be tailored for Florida or any U.S. market, arms pharmaceutical sales teams with local-level managed care market intelligence. To meet sales force needs, District, Area, Territory and Region Survival Kits are available.

Each Survival Kit can be customized to provide the most relevant quantitative and qualitative insights that will enable teams to assess priorities and understand market drivers, influencers and opportunities. Accurate and comprehensive enrollment information allows teams to evaluate how medical and pharmacy lives are covered in a particular district to improve strategic planning and resource allocation.

"Gathering market intelligence can be time-consuming and expensive, and without the validation of a third-party expert, companies often do not get the complete picture," said Jed Maley, vice president, business development with HealthLeaders-InterStudy. "Our survival kits combine our data and analysis products into a geography-specific kit, allowing sales teams to quickly gain knowledge about local and regional key players, and better understand the environment in which they operate to uncover new opportunities or better leverage existing ones."

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

###

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System
2. China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
3. ProSolv Version 4.0.2 Makes Commercial Debut at ASE
4. moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
5. Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
6. BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
7. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
8. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
9. Althea Technologies Completes New State-of-the-Art, Commercial-Scale, Biologics and Injectables Manufacturing Facility
10. Building on Growth, Virtify Adds to Executive Team and Expands Commercial Operations
11. InfuSystem Appoints Bryan Russo as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... TX (PRWEB) , ... September 20, 2017 , ... ... date of the much-anticipated fall event , Look Awesome This Autumn with ... personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique is ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that Clear Global ... support services market) has entered into an agreement on September 1, 2017 with ... PGSD is the first private Dental School to launch an online, accredited Post ...
(Date:9/20/2017)... ... , ... Compliancy Group is proud to announce that its ... another long-time client pass their Department of Health and Human Services (HHS) Office ... to the help of the Compliancy Group's Audit Response Program™, not a single ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short ... has already been receiving positive feedback from customers trying the product for the first ... Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods ... market impact in 27 different categories. Nopavera Plus was named to the ... be announced at SupplySide West 2017 during presentations at SupplySide Central on Sept. 27 ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017  For nearly two decades, New Life Agency has been committed ... industry. Today, New Life Agency announces a powerful three-way partnership designed to ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: